All News
Updated ACR/AAHKS Guidelines on Drug Use in Knee & Hip Arthroplasty Patients
ACR
The American College of Rheumatology and the American Association of Hip and Knee Surgeons released a summary of their updated guideline for the Perioperative Management of Antirheumatic Medication in Patients with Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
Read Article
Downside of Holding Methotrexate with COVID-19 Vaccination
A recent prospective, randomized, blinded clinical trial has shown that a 2 week hold of methotrexate (MTX) following COVID-19 (Sinovac-CoronaVac) vaccination resulted in greater anti-SARS-CoV-2 immunogenicity; but there was an increase in flare rates after the second dose of vaccine.
Read Article
🎯Giant cell tumor
🎯denosumab was used to decrease the stage of the local disease prior to surgical resection in 57% of patients #RheumTwitter #Rheumatology #Rheumato #denosumab
https://t.co/CBfW3gPvFV https://t.co/pEvo4jUnBH
Dr.Hala Fadhil MD drhalafadhil ( View Tweet)
Today is RARE DISEASE DAY
Retweet 🔄 to raise awareness
of rare #autoimmune diseases
such as #Lupus https://t.co/EfjOfvNh1h
Laurent ARNAUD Lupusreference ( View Tweet)
Drug Safety Advisories from regulators appears to reduce physician prescribing by 5.8%. Data from a study of 2 dozen advisories in 4 countries, Canada, Denmark, US, and UK between 2009 and 2015. https://t.co/TB6IeH9eGS https://t.co/2BiJJqQfSQ https://t.co/H3xuzyPJNX
Dr. John Cush RheumNow ( View Tweet)
Deaths due to non-benzodiazepine hypnotics and gabapentinoids increased significantly over the last two decades. Clinicians should not assume that replacing benzodiazepines and opioids with these medications necessarily lowers risk to the patient. https://t.co/hfwKElpdFc https://t.co/lgHyRv7OyQ
Links:
Dr. John Cush RheumNow ( View Tweet)
Medicines 10 Lowest Hourly Wages
1 FP $89/hr
2. Int Med $90
3 ID $92
4 Peds $94
5 Endo $100
6 Rheum $102
7 Prevent $105
8 Allergy $112
9 Neuro $114
10 Psych $117
https://t.co/EFTNYTUOgA https://t.co/wjcbC6dLML
Links:
Dr. John Cush RheumNow ( View Tweet)
Acute onset swelling in but a few joints. What's a hairdresser to do? What would you do?
QD Clinic is sponsored by https://t.co/4UQlqwujiR (March 19 & 20, 2022 in Las Colinas, Texas)
https://t.co/KYI05R1h5J https://t.co/GobpZ4TRhQ
Dr. John Cush RheumNow ( View Tweet)
Listen in… Fellow Case Presentations From RWCS 2022
https://t.co/SvaGfyDDTK https://t.co/MP9iWQK8ZB
Links:
Dr. John Cush RheumNow ( View Tweet)
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow. This week, rheumatologic problems incited by respiratory infections, air pollution and how you live, now where you live.
Download wherever you get your podcasts.
https://t.co/AR08F92XSY https://t.co/sqqlHvSHUL
Links:
Dr. John Cush RheumNow ( View Tweet)
ICYMI: Prevent NSAID GI bleeding or perforation? Korean study (n=92K) shows (vs non-prophylaxis) PPI and COX-2 inhibitors associated with 64% and 74% reduced risk. COX2 = PPI +nsNSAID. H2-receptor antag. did not reduce the risk https://t.co/pUuVzwiQgx https://t.co/JAUqW9AMck
Links:
Dr. John Cush RheumNow ( View Tweet)
ICYMI: 144 SLE pts from the SLICC cohort were studied showing that a majority (61.2%) scores consistent with depression over 4 yrs; also an inconsistent association between disease activity and depression in multivariate analysis https://t.co/YqxPFtYohf
Links:
Dr. John Cush RheumNow ( View Tweet)
ICYMI: Case showing flare of Dermatomyositis in a Patient With Psoriasis treated with Secukinumab. https://t.co/GvyXzcSNUa https://t.co/T83m5YojcH
Links:
Dr. John Cush RheumNow ( View Tweet)
In case you missed it…
RA: Still a Clinical Diagnosis
https://t.co/8RrhxAgbkP https://t.co/R9EpxSE9Gr
Links:
Dr. John Cush RheumNow ( View Tweet)
ICYMI: Positive Results from the DOA (Duloxetine in OsteoArthritis) Study
https://t.co/JU0OeQgmta https://t.co/IRv3C747Zt
Links:
Dr. John Cush RheumNow ( View Tweet)
New podcast available for download!
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow. This week, rheumatologic problems incited by respiratory infections, air pollution and how you live, now where you live.
https://t.co/jQAq6iBvca https://t.co/FgIG1ogPGo
Links:
Dr. John Cush RheumNow ( View Tweet)
We are excited to share that Kaleb Michaud, PhD, will be presenting on Adherence to Rheumatoid Therapies during our RA-Future Improvement Pod at RheumNow Live on 3/19.
Have you registered yet?
https://t.co/HOOMh84MF0 https://t.co/5lPijPoN9b
Links:
Dr. John Cush RheumNow ( View Tweet)
MMWR - NFL Study on When to Be Released if COVID(+)
MMWR has reported the results of the National Football Leagues (NFL) change in SARS-CoV-2 testing program that went into effect in December 2021.
https://t.co/EoIjc0XL0R https://t.co/ysRPao1oC2
Links:
Dr. John Cush RheumNow ( View Tweet)
COSMOS Study - Guselkumab Efficacy at 1 Year in Psoriatic Arthritis
https://t.co/kl6RzE6hK2 https://t.co/vLY2xQAqwn
Links:
Dr. John Cush RheumNow ( View Tweet)
FDA granted Breakthrough Therapy Designation Boehringer Ingelheims BI 1015550 - a oral, phosphodiesterase 4B inhibitor (antifibrotic & anti-inflammatory), now in phase II trials for idiopathic pulmonary fibrosis https://t.co/SMXEweSVAR
Links:
Dr. John Cush RheumNow ( View Tweet)
